WASHINGTON (AP) ? The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.
WASHINGTON (AP) ? Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.
The Senate on Tuesday unanimously confirmed former Procter & Gamble CEO Robert McDonald as the new Veterans Affairs secretary, with a mission to overhaul an agency beleaguered by long veterans' waits for health care and VA workers falsifying records to cover up delays.
By David Schwartz PHOENIX (Reuters) - A Phoenix Suns basketball player has been arrested on suspicion of super extreme DUI in Arizona after attempting to drive home after a night out, authorities said on Tuesday. Forward-guard P.J. Tucker, 29, was taken to jail and released following the incident, which took place in Scottsdale on May 10 but only came to light this week, according to a police report. Police said Tucker, considered a team leader by insiders, was returning home from the W Scottsdale Hotel when he was pulled over by police after allegedly running a stop sign. Super extreme DUI is .20 or above under Arizona law.
Pfizer Inc , which in May abandoned its $118 billion bid for AstraZeneca Plc , on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considering other deals. Under UK takeover rules, AstraZeneca can attempt to re-engage with Pfizer in August, and Pfizer can make another run at AstraZeneca in November. Pfizer officials on Tuesday gave no hints of whether they would do so, although Chief Executive Ian Read said Pfizer is not currently "doing any work on AstraZeneca" because of a six-month quiet period imposed by U.K. regulators. Pfizer officially gave up its six-month quest to buy AstraZeneca after its final bid was rejected on May 26.
Copyright (c) 2014 Yahoo! Inc. All rights reserved